Health Condition 1: null- Type 2 Diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients duration of type 2 diabetes mellitus 1-5 years subjects on stable statin therapy for a minimum period of three months vitamin D levels less than 20ng/mL Stable treated hypertension
Exclusion criteria
Exclusion criteria: 1 Other forms of Diabetes (T1DM Gestational diabetes mellitus 2 Known thyroid disorders 3 Known malignancy 4 Known cerebrovascular diseases 5 Known myocardial infarction 6 Chronic kidney diseases 7 Acute and chronic inflammatory diseases 8 Smokers and alcoholic 9 Pregnant and lactating women 10 Any change in treatment during the study period 11 Patients who are on insulin and lipid lowering drugs corticosteroids and vitamin D or calcium supplementation will be excluded from study
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Change in Lipid Profile Change in atherosclerotic biochemical markersTimepoint: After 3rd and 6th month of vitamin D supplementation | — |
Primary
| Measure | Time frame |
|---|---|
| Change in oxidant and antioxidant status MDA FRAP Change in inflammatory markers hsCRP IL 6 Change in Lipid Profile Change in atherosclerotic biochemical markers Oxidized LDL PAI 1 Fibrinogen Timepoint: After 3rd and 6th month of vitamin D supplementation | — |
Countries
India
Contacts
Sri Venkateswara Institute of Medical Sciences